Search results
Results from the WOW.Com Content Network
The stock price is now down about 10% on the year as of this writing. ... Zscaler trades at a forward price-to-sales multiple of about 9.6 based on current fiscal-year analyst estimates. Given its ...
Eli Lilly (NYSE: LLY) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose by more than 2% on the day, thanks largely to news from a rival. Eli ...
While its sales are in decline as Eli Lilly's newer GLP-1 drugs begin to take market share, the drug was still Eli Lilly's second-best-selling drug in the first half of 2024, with $2.7 billion in ...
The price a stock trades at can drastically impact your overall returns. ... I'll make the case for why pharma giant Eli Lilly (NYSE: LLY) still looks like a great buy right now -- even though it ...
Before you buy stock in Zscaler, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Zscaler wasn’t ...
Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been punished by investors. As of this writing, Lilly's stock price has plunged as ...
Eli Lilly (LLY) is experiencing a banner year, as its stock price has reached new all-time highs in June. The surge comes on the heels of a series of positive developments for the pharmaceutical ...
Eli Lilly (NYSE: LLY) is hogging the headlines as its market capitalization marches toward $1 trillion. But even as the market continues to evaluate the growing demand for anti-obesity drugs and ...